Anti-CK8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
US8778341B2 · kind B2 · utility
1Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 27, 2010 |
| Grant date | Jul 15, 2014 |
| Priority date | — |
| Expiry date | Jan 12, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antibodies specific to human CK8 and to pharmaceutical compositions for preventing and treating colorectal cancers. The invention also relates to methods for identifying colorectal cancers with an invasive and/or metastatic phenotype including detecting the cleavage of the C-terminal portion of human CK8 on the surface of tumor cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.